James A. Bianco - 06 Jan 2026 Form 4 Insider Report for TuHURA Biosciences, Inc./NV (HURA)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: HURA
Reported as of: 06 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jan 2026, 16:33:52 UTC
Prior SEC filing: 17 Dec 2025
Next SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dan Dearborn as Power of Attorney for James Bianco

Key filing fact

James A. Bianco filed Form 4 for TuHURA Biosciences, Inc./NV (HURA) on 08 Jan 2026.

Key facts

This page summarizes James A. Bianco's Form 4 filing for TuHURA Biosciences, Inc./NV (HURA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jan 2026, 16:33.

Change

Previous filing in this sequence was filed on 17 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001198554 Primary reporting owner

Bianco James A.

Relationship: Chief Executive Officer, Director
Address: 10500 UNIVERSITY CENTER DRIVE, SUITE 110, TAMPA
Signature: /s/ Dan Dearborn as Power of Attorney for James Bianco
Signature date: 08 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HURA transaction Derivative

Options (Right to Buy)

Award

Transaction value: $0
Shares: +610,332
Change %
Price: $0.000000
Shares after: 610,332
Date: 06 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 610,332
Exercise price: $0.7300
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a supplemental option grant to the option grant previously made in December 2025. One-third of the stock options become exercisable on the first, second, and third anniversary of January 6, 2025.